Market Cap:
24h Vol:
Stocklytics Platform
Asset logo  BMRN
BioMarin Pharmaceutical
77 / 100
High Growth

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

BioMarin Pharmaceutical (BMRN) Stocklytics Forecast

BioMarin Pharmaceutical Inc (BMRN) is a leading biotechnology company focused on developing innovative therapies for patients with rare genetic diseases. With a strong pipeline of potential treatments and a track record of success, BioMarin is well-positioned for future growth. The company's stock price has been a topic of interest for investors and analysts, with many seeking to predict its future performance.

While it is impossible to predict exactly where BioMarin's stock price will be in the future, there are several factors that could influence its trajectory. One important factor is the company's pipeline of new therapies. BioMarin has a number of promising drugs in development, including treatments for rare diseases such as phenylketonuria and hemophilia. If these drugs are successful in clinical trials and receive regulatory approval, they could drive significant revenue growth for the company and potentially boost its stock price.

add BioMarin Pharmaceutical  to watchlist

Keep an eye on BioMarin Pharmaceutical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

What is the analyst price prediction for BioMarin Pharmaceutical (BMRN) stock?

Analysts have set a target price of $111.18 for BioMarin Pharmaceutical (BMRN), based on forecasts from 22 analysts. The predicted price range extends from a high of $140 to a low of $73. This represents a potential increase of up to 84.45% and a decrease of -3.82% from the current price of $75.9. These forecasts are as of 2023 Jun 30.

What are the analyst ratings for BioMarin Pharmaceutical (BMRN) stock?

Currently, there are no analyst ratings available for BioMarin Pharmaceutical (BMRN), possibly due to insufficient coverage or recent updates.

What is the AI price prediction for BioMarin Pharmaceutical (BMRN) stock?

At present, there is no AI or machine-learning-based price prediction available for BioMarin Pharmaceutical (BMRN) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.


Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level